Wormser, Gary P, Shapiro, Eugene D · Journal of women's health (2002) · 2009 · DOI
Quick Summary
This study compared three groups of patients: those with confirmed Lyme disease, those with lingering symptoms after Lyme disease treatment (post-Lyme disease syndrome), and those diagnosed with 'chronic Lyme disease' (a less clearly defined condition). The researchers found that women made up a much larger percentage of the chronic Lyme disease group compared to the other two groups. This suggests that some patients labeled with chronic Lyme disease may actually have other conditions like fibromyalgia or chronic fatigue syndrome that also affect more women.
Why It Matters
This study is relevant to ME/CFS patients because it highlights diagnostic confusion between Lyme disease, post-Lyme disease syndrome, and other unexplained post-infectious conditions that predominantly affect women. The finding that 'chronic Lyme disease' may represent misclassified cases of ME/CFS or similar conditions underscores the importance of accurate differential diagnosis and the risk of missing true ME/CFS cases in patients with Lyme exposure.
Observed Findings
Patients with chronic Lyme disease were 2.42 times more likely to be female than patients with confirmed Lyme disease (95% CI 1.98-2.94, p<0.0001).
Patients with chronic Lyme disease were 2.32 times more likely to be female than patients with post-Lyme disease syndrome (95% CI 1.62-3.34, p<0.0001).
Confirmed Lyme disease and post-Lyme disease syndrome showed roughly equal gender distributions (similar to the general CDC-reported case population).
The chronic Lyme disease group (n=490) showed markedly female-skewed demographics compared to both other groups.
Inferred Conclusions
The gender distribution of chronic Lyme disease differs significantly from both B. burgdorferi infection and post-Lyme disease syndrome, suggesting these are distinct patient populations.
The female preponderance in chronic Lyme disease may reflect misdiagnosis of female-predominant conditions such as fibromyalgia, ME/CFS, or depression.
Clinicians should consider differential diagnosis when evaluating women with unexplained post-infectious symptoms attributed to Lyme disease.
Remaining Questions
Does the gender disparity reflect true biological differences in B. burgdorferi response, or diagnostic bias and labeling patterns in clinical practice?
What is the actual frequency of ME/CFS, fibromyalgia, and depression in patients labeled with chronic Lyme disease, and how much diagnostic misclassification occurs?
What This Study Does Not Prove
This study does not prove that chronic Lyme disease diagnoses are incorrect or that B. burgdorferi cannot cause prolonged symptoms. It does not establish whether women with chronic Lyme disease actually have ME/CFS, fibromyalgia, or depression—only that gender distribution differs. The cross-sectional design cannot determine causality or whether gender differences reflect true biological differences, diagnostic bias, or healthcare-seeking behavior differences.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.